Metronidazole: Difference between revisions
No edit summary |
|||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
'''Metronidazole''' ([[International Nonproprietary Name|INN]]) {{IPAc-en|m|ɛ|t|r|ə|ˈ|n|aɪ|d|ə|z|oʊ|l}} (Flagyl,FILMET and others) is a [[nitroimidazole]] [[antibiotic]] medication used particularly for [[anaerobe|anaerobic]] [[bacterium|bacteria]] and [[protozoa]]. Metronidazole is an antibiotic, amebicide, and antiprotozoal.<ref name=monograph/> | |||
It is the drug of choice for first episodes of mild-to-moderate ''[[Clostridium difficile]]'' infection.<ref> | |||
{{cite doi | 10.1086/651706 }}</ref> | |||
It is marketed in the [[United States]] by [[Pfizer]] and globally by [[Sanofi]] under the trade name '''Flagyl''', and is also sold under other brand names. In Bangladesh it is marketed by [[Beximco Pharma]] under the trade name of Filmet. Metronidazole was developed in 1960. | |||
Metronidazole is used also as a gel preparation in the treatment of the [[dermatology|dermatological]] conditions such as [[rosacea]] ('''Rozex''' and '''MetroGel''' by [[Galderma]]) and [[neoplasia|fungating]] [[tumour]]s ('''Anabact''', Cambridge Healthcare Supplies). | |||
==Category== | ==Category== | ||
Revision as of 23:01, 8 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]
Overview
Metronidazole (INN) /mɛtrəˈnaɪdəzoʊl/ (Flagyl,FILMET and others) is a nitroimidazole antibiotic medication used particularly for anaerobic bacteria and protozoa. Metronidazole is an antibiotic, amebicide, and antiprotozoal.[1] It is the drug of choice for first episodes of mild-to-moderate Clostridium difficile infection.[2] It is marketed in the United States by Pfizer and globally by Sanofi under the trade name Flagyl, and is also sold under other brand names. In Bangladesh it is marketed by Beximco Pharma under the trade name of Filmet. Metronidazole was developed in 1960.
Metronidazole is used also as a gel preparation in the treatment of the dermatological conditions such as rosacea (Rozex and MetroGel by Galderma) and fungating tumours (Anabact, Cambridge Healthcare Supplies).
Category
US Brand Names
FDA Package Insert
Description | Clinical Pharmacology | Microbiology | Indications and Usage | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Overdosage | Clinical Studies | Dosage and Administration | How Supplied | Labels and Packages